| 000 | 01352 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512050847.0 | ||
| 264 | 0 | _c19880705 | |
| 008 | 198807s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1988.tb03274.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChoonara, I A | |
| 245 | 0 | 0 |
_aThe relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJan 1988 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBlood Coagulation Factors _xphysiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 | _aVitamin K Epoxide Reductases |
| 650 | 0 | 4 |
_aWarfarin _xpharmacology |
| 700 | 1 | _aMalia, R G | |
| 700 | 1 | _aHaynes, B P | |
| 700 | 1 | _aHay, C R | |
| 700 | 1 | _aCholerton, S | |
| 700 | 1 | _aBreckenridge, A M | |
| 700 | 1 | _aPreston, F E | |
| 700 | 1 | _aPark, B K | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 25 _gno. 1 _gp. 1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1988.tb03274.x _zAvailable from publisher's website |
| 999 |
_c3375924 _d3375924 |
||